Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.
The risk for ischemic colitis is higher among older women with low diastolic blood pressure and those taking at least two antihypertensive medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results